In our study, we found that the dual PI3K/mTOR inhibitor selectively inhibited NPC cells proliferation and suppressed the PI3K/mTOR activity both in vivo and in vitro (Fig. 1, Fig. 2, Fig. 6A–E). Here, MTOR is linked to nasopharyngeal carcinoma.